Successes in liver disease treatment
Zurich - Versantis has achieved positive results in a phase 1B study involving its medicinal product VS-01, which aims to help people with liver diseases.
Investors back Keros Digital
Mendrisio TI – Italy’s Holding Polo Digitale and the Digital Native Capital fund from Luxembourg are taking over 100 percent of the capital in Keros Digital. What’s more, the e-commerce technology specialist will receive a significant capital injection from the two companies.
Researchers make virtual keyboard a reality
Zurich – Researchers at ETH Zurich have developed a sensor wristband that detects finger movement. This brings intuitive free-hand interaction to virtual productivity spaces. With this, a tabletop or thigh can be transformed into a keyboard, for example.
SHL Medical to construct new, sustainable site
Zug - SHL Medical is to build a combined production facility and office space at the Tech Cluster Zug. The construction concept is being realized by the Penzel Valier AG. The new building, which will be mainly built from wood, will be powered by solar energy and heated using lake water.
Rqmicro successfully closes debut financing round
Schlieren ZH – The start-up rqmicro has secured investment totaling 6 million Swiss francs as part of a debut financing round. A second financing round is expected to follow by the middle of this year. Rqmicro offers solutions for the detection of water-based bacteria.
Investors pledge 4.5 million US dollars for cultivated meat
Wädenswil ZH - The start-up Mirai Foods has raised around 2.2 million US dollars in a second tranche of a seed financing round. Overall, a total of 4.5 million US dollars of fresh capital has now been raised. The start-up’s activities are focused on the production of artificially cultivated meat products.
First IT students graduate from SIT
Schaffhausen - The Schaffhausen Institute of Technology has awarded diplomas to the first seven students enrolled in its master’s program in computer science. The second course at the private university started recently, with a total of 29 students enrolled on this occasion.
New weapon against COVID-19 for the medical world
Bellinzona - The COVID-19 drug developed by Humabs Biomed is so effective that several countries have now lodged Emergency Use Authorization applications. The antibody therapy helps to cut hospitalization and death rates by 85 percent. Moreover, it is also effective against current mutations.
Empa extracts melanin from fungus
Dübendorf ZH – Researchers at Empa have succeeded in extracting large amounts of melanin from a fungus. Due to its ability to absorb harmful substances, it could be used to manufacture innovative materials, for example. In addition, a historic instrument is being revived.
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.